EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Natural Killer Cell-Derived Extracellular Vesicles Exhibit Cytotoxicity Against Bulk Tumor Cells and Cancer Stem Cells in Triple-Negative Breast Cancer

Melanie Kirkby, Frederic St-Denis-Bissonnette iD, Marena D Diab, Karan Mediratta, Anna Korobkow, James Humber, Peter Han, Gauri Muradia, Michele Ardolino iD, Seung-Hwan Lee iD, Derrick J Gibbings, Dylan Burger iD und 2 weitere

Nanomaterials · 27.04.2026 · 16 (9) · 525

DOI: 10.3390/nano16090525 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanomaterials, online erschienen am 27.04.2026. Verfasst von Melanie Kirkby und 13 weiteren Autor:innen. Beteiligte Einrichtung: Biologic and Radiopharmaceutical Drugs Directorate, Health Canada, Ottawa, ON K1A 0K9, Canada. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, Cancer Research Society, CIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) remains a significant challenge in oncology, contributing to a significant portion of cancer-related deaths among women. Current therapeutic options, including chemotherapy, surgery, radiation, and hormonal targeting therapies, exhibit limited efficacy, necessitating the exploration of innovative treatment modalities. The emergence of drug resistance and the persistence of cancer stem cells (CSCs) further emphasize the urgent need for novel therapeutic strategies. In this context, natural killer cell-derived extracellular vesicles (NK-EVs) have emerged as a promising cell-free therapeutic approach that exhibits high tumor infiltration and cytotoxicity against cancer cells and CSCs. This study aims to investigate the efficacy of NK-EVs as a therapeutic strategy for TNBC using various clinically relevant models, including patient-derived xenografts. Pathway analysis suggests strong activation of apoptosis via canonical caspase activation, as well as necrosis, thereby confirming the important cytotoxic effect of NK-EVs. Interestingly, NK-EVs were also found to suppress TNBC CSCs by disrupting their functionality and viability, and NK-EV treatment increased the expression of apoptosis markers in both CSCs and non-CSCs. By elucidating the therapeutic efficacy and translational potential of NK-EV-based interventions in TNBC, these findings offer critical insights for the development of future immunotherapeutic strategies against this aggressive subtype of breast cancer.

Schlagwörter

Stichwörter der Autor:innen

cancer stem cells (CSCs)natural killer cell-derived extracellular vesicles (NK-EVs)patient-derived xenograft (PDX)solid tumortriple-negative breast cancer (TNBC)

Autor:innen und Institutionen

  • Biologic and Radiopharmaceutical Drugs Directorate, Health Canada, Ottawa, ON K1A 0K9, Canada.
  • Department of Biochemistry, Immunology and Microbiology, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
  • Centre for Infection, Immunity and Inflammation, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
  • Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada.
  • Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON K1H 8M5, Canada.
  • Kidney Research Centre, Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada.

ORCID-Profile: Frederic St-Denis-Bissonnette, Michele Ardolino, Seung-Hwan Lee, Dylan Burger, Lisheng Wang

Förderung

  • Natural Sciences and Engineering Research Council of Canada
  • Cancer Research Society
  • CIHR
  • Government of Canada
  • Natural Sciences and Engineering Research Council
  • Canadian Institutes of Health Research
  • CIHR’s Canadian Graduate Scholarship—Master’s Program
  • Ontario Graduate Scholarship—Master’s Program

Zitieren

APA

Kirkby, M., St-Denis-Bissonnette, F., Diab, M. D., Mediratta, K., Korobkow, A., Humber, J., Han, P., Muradia, G., Ardolino, M., Lee, S. H., Gibbings, D. J., Burger, D., Wang, L., & Lavoie, J. R. (2026). Natural Killer Cell-Derived Extracellular Vesicles Exhibit Cytotoxicity Against Bulk Tumor Cells and Cancer Stem Cells in Triple-Negative Breast Cancer. Nanomaterials, 16(9), 525. https://doi.org/10.3390/nano16090525

Vancouver

Kirkby M, St-Denis-Bissonnette F, Diab MD, Mediratta K, Korobkow A, Humber J, et al. Natural Killer Cell-Derived Extracellular Vesicles Exhibit Cytotoxicity Against Bulk Tumor Cells and Cancer Stem Cells in Triple-Negative Breast Cancer. Nanomaterials. 2026;16(9):525. doi:10.3390/nano16090525

BibTeX
@article{Kirkby2026,
  author = {Kirkby, Melanie and St-Denis-Bissonnette, Frederic and Diab, Marena D and Mediratta, Karan and Korobkow, Anna and Humber, James and Han, Peter and Muradia, Gauri and Ardolino, Michele and Lee, Seung-Hwan and Gibbings, Derrick J and Burger, Dylan and Wang, Lisheng and Lavoie, Jessie R},
  title = {Natural Killer Cell-Derived Extracellular Vesicles Exhibit Cytotoxicity Against Bulk Tumor Cells and Cancer Stem Cells in Triple-Negative Breast Cancer},
  journal = {Nanomaterials},
  year = {2026},
  volume = {16},
  number = {9},
  pages = {525},
  doi = {10.3390/nano16090525}
}
Kostenlos starten →